Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: J Neurooncol. 2017 Aug 21;135(2):403–411. doi: 10.1007/s11060-017-2588-4

Table 2.

Discrimination measures and hazard ratios for prognostic groups based on percentiles of the prognostic index (PI) evaluated in the training and validation datasets

Measure Training
Estimate (SE)
Validation 1
Estimate (SE)
Validation 2
Estimate (SE)
Harrell c-index 0.659 (0.018) 0.631 (0.018) 0.644 (0.030)
Gönen and Keller K 0.628 (0.003) 0.629 (0.003) 0.635 (0.006)
Explained variation (rD2) 0.133 (0.029) 0.124 (0.033) 0.140 (0.055)
Heller’s estimated explained relative risk 0.178 (0.043) 0.173 (0.048) 0.196 (0.080)

Training
HR (95% CI)
Validation 1
HR (95% CI)
Validation 2
HR (95% CI)

Prognostic index category (<16th percentile) Referant Referant Referant
 16th to <50th percentile 1.48 (0.97–2.25) 1.49 (0.86–2.58) 0.93 (0.47–1.83)
 50th to <84th percentile 2.91 (1.96–4.32) 2.27 (1.33–3.85) 2.32 (1.24–4.35)
 84th percentile or greater 4.44 (2.86–6.89) 4.17 (2.40–7.24) 3.07 (1.56–6.02)

Standard errors (SE) for the c-index, K, and rD2 were estimated from 200 bootstrap samples. Hazard ratios (HR) are relative to the reference group of PI <16th percentile CI confidence interval